These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38685716)
1. Hydralazine use can be associated with IgM-dominated immune complex-mediated glomerulonephritis. Zhang PL; Metcalf BD; Khan S; Abukhaled J; Zafar K; Li W; Kanaan HD Ultrastruct Pathol; 2024 Jul; 48(4):317-322. PubMed ID: 38685716 [TBL] [Abstract][Full Text] [Related]
2. The clinical features of overlap syndrome (ANCA-associated crescentic glomerulonephritis [AACGN] and immune complex-mediated glomerulonephritis) are similar to those of AACGN alone. Golas VL; Lao KM; Misuraca MS; Li W; Marrone MG; Kanaan HD; Zhang PL Int Urol Nephrol; 2021 Mar; 53(3):515-521. PubMed ID: 33025405 [TBL] [Abstract][Full Text] [Related]
3. Simultaneous occurrence of fibrillary glomerulonephritis and renal lesions in nonmalignant monoclonal IgM gammopathy. Wu CK; Leu JG; Yang AH; Tarng DC; Tung HY; Chiang SS BMC Nephrol; 2016 Feb; 17():17. PubMed ID: 26892336 [TBL] [Abstract][Full Text] [Related]
8. Hydralazine-induced ANCA-positive pauci-immune glomerulonephritis: a case report and literature review. Dobre M; Wish J; Negrea L Ren Fail; 2009; 31(8):745-8. PubMed ID: 19814644 [TBL] [Abstract][Full Text] [Related]
10. A patient presenting with isolated hematuria and renal dysfunction as rare manifestation of cryoglobulinemic glomerulonephritis in the course of autoimmune diseases including Sjögren's syndrome. Yamanaka M; Fujigaki Y; Kono H; Nagura M; Arai S; Tamura Y; Ota T; Shibata S; Kondo F; Yamaguchi Y; Uchida S CEN Case Rep; 2018 Nov; 7(2):211-216. PubMed ID: 29671215 [TBL] [Abstract][Full Text] [Related]
11. Occurrence of autoantibodies directed against myeloperoxidase and elastase in patients treated with hydralazine and presenting with glomerulonephritis. Torffvit O; Thysell H; Nässberger L Hum Exp Toxicol; 1994 Aug; 13(8):563-7. PubMed ID: 7946512 [TBL] [Abstract][Full Text] [Related]
12. Experimental proliferative glomerulonephritis in the cat. Bishop SA; Stokes CR; Lucke VM J Comp Pathol; 1992 Jan; 106(1):49-60. PubMed ID: 1556257 [TBL] [Abstract][Full Text] [Related]
13. Two adult cases of IgM-associated mesangial proliferative glomerulonephritis. Hishiki T; Tomino Y; Inokuchi S; Shirato I; Ebihara I; Kubota M; Nakayama S; Koide H Nihon Jinzo Gakkai Shi; 1994 Aug; 36(8):942-6. PubMed ID: 7933671 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal immunoglobulin-associated proliferative glomerulonephritis characterized by organized deposits of striated ultra-substructures: A case report. Hara S; Tsukaguchi H; Oka T; Kusabe M; Mizui M; Joh K Ultrastruct Pathol; 2017; 41(4):301-307. PubMed ID: 28628381 [TBL] [Abstract][Full Text] [Related]
16. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases. Haas M; Eustace JA Kidney Int; 2004 Jun; 65(6):2145-52. PubMed ID: 15149327 [TBL] [Abstract][Full Text] [Related]
18. Immune-complex glomerulonephritis with a membranoproliferative pattern in Frasier syndrome: a case report and review of the literature. Matsuoka D; Noda S; Kamiya M; Hidaka Y; Shimojo H; Yamada Y; Miyamoto T; Nozu K; Iijima K; Tsukaguchi H BMC Nephrol; 2020 Aug; 21(1):362. PubMed ID: 32838737 [TBL] [Abstract][Full Text] [Related]
19. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. Johnson RJ; Gretch DR; Yamabe H; Hart J; Bacchi CE; Hartwell P; Couser WG; Corey L; Wener MH; Alpers CE N Engl J Med; 1993 Feb; 328(7):465-70. PubMed ID: 7678440 [TBL] [Abstract][Full Text] [Related]
20. Antibodies to neutrophil granulocyte myeloperoxidase and elastase: autoimmune responses in glomerulonephritis due to hydralazine treatment. Nässberger L; Johansson AC; Björck S; Sjöholm AG J Intern Med; 1991 Mar; 229(3):261-5. PubMed ID: 1848881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]